LBA34 Association of homologous recombination deficiency (HRD) with clinical outcomes in a phase III study of olaparib or cediranib and olaparib compared to platinum-based chemotherapy in recurrent platinum-sensitive ovarian cancer (PSOC): Biomarker analyses from NRG-GY004
| Autor: | Swisher, E., Miller, A., Kohn, E., Brady, M., Radke, M., Pennil, C., Khasnavis, N., Buscema, J., Tew, W., Muller, C., Hill, E., Moore, R., Michelin, D., Waggoner, S., Geller, M., Fujiwara, K., D'Andre, S., Liu, J., Birrer, M.J. |
|---|---|
| Zdroj: | In Annals of Oncology September 2021 32 Supplement 5:S1309-S1309 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|